SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-022647
Filing Date
2016-08-04
Accepted
2016-08-04 15:33:13
Documents
49
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nktr-10q_20160630.htm 10-Q 1344994
2 EX-10.1 nktr-ex101_193.htm EX-10.1 604791
3 EX-31.1 nktr-ex311_8.htm EX-31.1 16067
4 EX-31.2 nktr-ex312_6.htm EX-31.2 16079
5 EX-32.1 nktr-ex321_7.htm EX-32.1 7771
6 GRAPHIC gbljdgkle2s3000002.jpg GRAPHIC 34178
7 GRAPHIC gbljdgkle2s3000001.jpg GRAPHIC 1088
  Complete submission text file 0001564590-16-022647.txt   4862473

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT nktr-20160630.xml EX-101.INS 692069
9 XBRL TAXONOMY EXTENSION SCHEMA nktr-20160630.xsd EX-101.SCH 43507
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktr-20160630_cal.xml EX-101.CAL 43986
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktr-20160630_def.xml EX-101.DEF 94673
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktr-20160630_lab.xml EX-101.LAB 283757
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktr-20160630_pre.xml EX-101.PRE 196059
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 161807124
SIC: 2834 Pharmaceutical Preparations